SBIR

Space Resources Startup Interlune Raises $18 Million in Seed Capital

Retrieved on: 
Wednesday, March 13, 2024
Astronaut, Government, Alphabet, Apollo, Blue Origin, National Science Foundation, Natural Resources, Shasta Ventures, SBIR, History, University, University of Michigan, Spaceflight Industries, NSF, Investment, Liquid, Water, Rocket Lab, Small Business Innovation Research, Renewable energy

SEATTLE, March 13, 2024 /PRNewswire/ -- Interlune, a natural resources company, emerged from stealth today, announcing that it has raised funding to further develop and operationalize technology to extract Helium-3 and other natural resources from the Moon. The funding is an essential milestone for Interlune in pursuing its mission to lead the world in sustainable, responsible harvesting and distribution of natural resources from space to benefit humanity.

Key Points: 
  • The funding is an essential milestone for Interlune in pursuing its mission to lead the world in sustainable, responsible harvesting and distribution of natural resources from space to benefit humanity.
  • Alexis Ohanian's venture firm Seven Seven Six led the most recent round of $15 million, adding to previous angel investments.
  • Katelin Holloway, founding partner of Seven Seven Six, will join the Interlune board of directors.
  • "For the first time in history, harvesting natural resources from the Moon is technologically and economically feasible," said Meyerson.

Sunairio Wins NSF Grant for New Climate Simulation Technology

Retrieved on: 
Tuesday, March 12, 2024
Climate change, National Science Foundation, Risk, Climate, SBIR, Research, Management science, AI, Wind, Northwestern University, Statistics, Doctor of Philosophy, NSF, Industrial engineering, Emeritus, IPCC, Small Business Innovation Research, Weather, Renewable energy

BALTIMORE, Md., March 12, 2024 /PRNewswire-PRWeb/ -- Sunairio, the first software platform to leverage hyperlocal climate simulation for energy prediction, today announced it has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I grant. The NSF SBIR program, which selects less than 14% of applying startups, funds high-impact technological research and development (R&D) across a wide range of disciplines.

Key Points: 
  • BALTIMORE, Md., March 12, 2024 /PRNewswire-PRWeb/ -- Sunairio , the first software platform to leverage hyperlocal climate simulation for energy prediction, today announced it has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I grant.
  • The NSF SBIR program , which selects less than 14% of applying startups, funds high-impact technological research and development (R&D) across a wide range of disciplines.
  • —Rob Cirincione, CEO of Sunairio
    For Sunairio, the award will fund research into a new, highly scalable climate simulation engine that promises to generate climate insights for the energy sector at 1,000 times the resolution of traditional, physics-based global climate models, such as the ones which support the body of research conducted by the Intergovernmental Panel on Climate Change (IPCC).
  • To stay up-to-date on milestones related to this research and other initiatives at Sunairio, or to explore collaboration opportunities, please send an email to [email protected] .

Vibronyx Awarded SBIR Phase II Contract by AFWERX to Enhance U.S. Air Force Operations with Digital Supply Chain Twin

Retrieved on: 
Tuesday, March 12, 2024
AFWERX, SBIR, DSCT, Small business, Air force, DAF, C-130, The, AFSOC, Telescopic sight

Nashville, Tennessee--(Newsfile Corp. - March 12, 2024) - Vibronyx, Inc., a minority- and veteran-owned analytics technology and services company, has been awarded a Small Business Innovative Research (SBIR) Phase II contract by AFWERX worth $1.25 million to enhance the company's AI-powered Digital Supply Chain Twin (DSCT) to support the Department of the Air Force (DAF).

Key Points: 
  • Nashville, Tennessee--(Newsfile Corp. - March 12, 2024) - Vibronyx, Inc., a minority- and veteran-owned analytics technology and services company, has been awarded a Small Business Innovative Research (SBIR) Phase II contract by AFWERX worth $1.25 million to enhance the company's AI-powered Digital Supply Chain Twin (DSCT) to support the Department of the Air Force (DAF).
  • The contract specifically develops a digital supply chain twin of the C-130 platform, enabling more resilient capabilities for the Air Force Special Operations Command (AFSOC).
  • Vibronyx has been awarded a Small Business Innovative Research Phase II contract by AFWERX worth $1.25 million to enhance the company's AI-powered Digital Supply Chain Twin to support the Department of the Air Force.
  • Vibronyx's DSCT technology will provide a comprehensive view of the C-130 supply chain, leveraging modern technologies like GenAI and simulation analysis to improve contingency planning and predictive maintenance.

Allyx Therapeutics Announces Positive Phase 1b Multiple Ascending Dose Data and Advances ALX-001 to Patients

Retrieved on: 
Monday, March 11, 2024
Bangladesh Technical Education Board, SBIR, Research, Toxicity, FDA, Food, Conference, Small Business Innovation Research, Safety, Therapy, Pharmacokinetics, Patient, Glutamate (neurotransmitter), Ageing, Pharmaceutical industry

NEW HAVEN, Conn., March 11, 2024 (GLOBE NEWSWIRE) -- Allyx Therapeutics, a clinical-stage biotechnology company, announced that its lead compound, ALX-001, is ready to proceed to Phase 2 clinical development in Alzheimer’s and Parkinson’s disease. This announcement was made in conjunction with the presentation of positive findings from the company’s Phase 1b multiple ascending dose study at the AD/PD™ 2024 Conference in Lisbon. ALX-001 is a highly selective, first-in-class, synapse-targeted, disease-modifying oral therapy in development for neurodegenerative diseases.

Key Points: 
  • This announcement was made in conjunction with the presentation of positive findings from the company’s Phase 1b multiple ascending dose study at the AD/PD™ 2024 Conference in Lisbon.
  • ALX-001 is a highly selective, first-in-class, synapse-targeted, disease-modifying oral therapy in development for neurodegenerative diseases.
  • The multiple ascending dose study (NCT05804383) examined the safety, tolerability and pharmacokinetics of twice-daily oral doses of ALX-001 in 32 heathy adult participants aged 50-80.
  • Allyx Therapeutics has initiated a 28-day safety study of ALX-001 in Alzheimer’s disease patients (NCT05804383) and is initiating a study in Parkinson’s disease patients.

NAPIGEN, Inc. Secures U.S. Patent, Awarded USDA SBIR Grant

Retrieved on: 
Monday, March 11, 2024
SBIR, CRISPR, Biotechnology, Climate, Farmer, Patent, Plant, Cell, Business development, Small Business Innovation Research, Mitochondrion, Plastid, RNA, Genome, United, Intellectual property, Food security, Pollen, DNA

The patented claims of US11920140 are directed to methods for altering the genomes of mitochondria or plastids.

Key Points: 
  • The patented claims of US11920140 are directed to methods for altering the genomes of mitochondria or plastids.
  • The mitochondria, also known as the powerhouses of cells, are critical components of plant, fungal, algal, and animal cells.
  • It is the third SBIR grant the company has received since its founding in 2016.
  • NAPIGEN, Inc. expects to complete a Series A financing this year to advance partnerships with agricultural companies to bring products to market.

Mattermost Completes Contract with U.S. Air Force 618th Air Operations Center to Deliver Real Time, Mission Critical Communications

Retrieved on: 
Tuesday, March 5, 2024
AFWERX, SBIR, Air force, Eighteenth Air Force, Intelligence, Mattermost, Air Operations Center, AFRL, Air Mobility Command, AOC, Partnership, Telescopic sight

Developed for the 618th Air Operations Center (AOC) of the United States Air Force Air Mobility Command, the four new features address C2 challenges with response time to mission-critical requests for information.

Key Points: 
  • Developed for the 618th Air Operations Center (AOC) of the United States Air Force Air Mobility Command, the four new features address C2 challenges with response time to mission-critical requests for information.
  • Air Force operators of any kind using Mattermost can leverage the features developed under this AFWERX Phase II to enhance mission intelligence shareability in real-time.
  • Message Acknowledgement - Improves situational awareness and synchronization on mission intelligence through enhanced visibility of message receipt across the chain of command.
  • User Group Management - Drives alignment across groups of rotating personnel during a mission, including operators and aircrews at the tactical edge.

Allyx Therapeutics Announces Expansion into Parkinson’s Disease Clinical Research with Lead Compound ALX-001 Following IND Acceptance

Retrieved on: 
Tuesday, March 5, 2024
Bangladesh Technical Education Board, SBIR, Research, New Drug Application, Synapse, FDA, Food, Conference, Small Business Innovation Research, Safety, Therapy, Pharmacokinetics, Patient, IND, Glutamate (neurotransmitter), Pharmaceutical industry

A 28-day safety study of ALX-001 in Parkinson’s disease patients will be initiated in Q1 2024.

Key Points: 
  • A 28-day safety study of ALX-001 in Parkinson’s disease patients will be initiated in Q1 2024.
  • “We are working with urgency to understand how the unique mechanism of action of ALX-001 at mGluR5, which preserves and protects synapses, can introduce meaningful clinical benefits for people living with Alzheimer’s disease and Parkinson’s disease,” commented Allyx Therapeutics co-founder and CEO Stephen Bloch, M.D.
  • As studies in Parkinson’s disease begin, the company will continue to advance clinical development of ALX-001 in Alzheimer’s disease, which is funded through grants from the National Institutes of Health and other Alzheimer’s disease research nonprofit organizations.
  • Fox Foundation for Parkinson’s Research contributes to research efforts around the potential of ALX-001, enabling our work to move into clinical research without delay,” commented Tim Siegert, Ph.D., chief operating officer and co-founder of Allyx Therapeutics.

Xwing Wins Army xTech SBIR Autonomy Contract

Retrieved on: 
Wednesday, March 6, 2024
Technology, Other Defense, Contracts, Air, Transport, Other Technology, Aerospace, Manufacturing, Defense, Robotics, SBIR, Multimedia, Aviation, Airport, ACE, Exercise, Army, Atmosphere of Earth, Safety, Cessna 208 Caravan, United States Army, Science, Gasoline

Xwing, a leading defense and aviation autonomy technology startup, today announced that it was advanced as a winner of a Phase I SBIR from the Army xTech SBIR Autonomy program.

Key Points: 
  • Xwing, a leading defense and aviation autonomy technology startup, today announced that it was advanced as a winner of a Phase I SBIR from the Army xTech SBIR Autonomy program.
  • In the coming months, Xwing will showcase its ability to conduct autonomous airlift and logistics missions during live operational demonstrations for Army stakeholders.
  • Xwing is a key partner of the Air Force’s AFWERX Autonomy Prime program.
  • Last month, Xwing was awarded a Military Approval to fly autonomous cargo missions during the Air Force’s AGILE FLAG 24-1 .

General John W. Raymond Joins Board of Impulse Space; Company Recently Selected for Two SBIR Awards by SpaceWERX

Retrieved on: 
Wednesday, February 21, 2024
Science, Satellite, Defense, Research, Contracts, Technology, Aerospace, Manufacturing, Transfer, Impulse, SBIR, Mira, Intelligence, Ethane, Helios, GEO, Transport, Government, OTV, Nitrous oxide, MEO, Space force, Space, LEO, Solar System, Communications satellite

Impulse Space , a leader of in-space transportation services, has recently welcomed General John W. “Jay” Raymond to its board of directors, bringing decades of experience in government space operations to the Impulse team.

Key Points: 
  • Impulse Space , a leader of in-space transportation services, has recently welcomed General John W. “Jay” Raymond to its board of directors, bringing decades of experience in government space operations to the Impulse team.
  • As a board member, General Raymond will support and advise the Impulse team in its work with government partners and customers.
  • “I am honored to join the Impulse Space team,” said General Raymond.
  • With a vision to enable in-space transportation throughout the solar system, Impulse Space is poised to serve customers across industries.

Springbok Analytics Receives $1.7m Phase II SBIR Grant from the NIH to Advance its Rotator Cuff Muscle Analysis Technology

Retrieved on: 
Tuesday, March 5, 2024
Data science, Bangladesh Technical Education Board, NP-hardness, SBIR, Research, Doctor of Philosophy, AI, University of Virginia, NIH, Shoulder, Pathology, FDA, Elective surgery, 3D, Surgeon, Entrepreneurship, University, Therapy, Tears, Scientific Reports, Jan Vansina, Patient, RC, Diagnosis, Machine learning, Muscle atrophy, Springbok, Atrophy, Artificial intelligence, MRI, Medical imaging

"Springbok has the potential to significantly enhance how we understand, manage, and treat RC tears and improve surgical outcomes.

Key Points: 
  • "Springbok has the potential to significantly enhance how we understand, manage, and treat RC tears and improve surgical outcomes.
  • Springbok's technology overcomes these two challenges through the use of AI and innovative analysis methods, described in recent studies in Radiology: Artificial Intelligence and Scientific Reports .
  • Leveraging its proprietary muscle analytics, Springbok's AI technology produces an enhanced RC analysis from standard MRIs that are acquired within the clinical workflow.
  • "Phase I demonstrated implementation viability of our new analysis, proving it was both valuable and practical within the clinical setting.